Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.
Mollnau H, Oelze M, Zinßius E, Hausding M, Wu Z, Knorr M, Ghaemi Kerahrodi J, Kröller-Schön S, Jansen T, Teutsch C, Foster C, Li H, Wenzel P, Schulz E, Münzel T, Daiber A. Mollnau H, et al. Among authors: hausding m. Naunyn Schmiedebergs Arch Pharmacol. 2013 May;386(5):405-19. doi: 10.1007/s00210-013-0842-7. Epub 2013 Feb 27. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23443495
Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.
Schuhmacher S, Oelze M, Bollmann F, Kleinert H, Otto C, Heeren T, Steven S, Hausding M, Knorr M, Pautz A, Reifenberg K, Schulz E, Gori T, Wenzel P, Münzel T, Daiber A. Schuhmacher S, et al. Among authors: hausding m. Diabetes. 2011 Oct;60(10):2608-16. doi: 10.2337/db10-1395. Epub 2011 Aug 15. Diabetes. 2011. PMID: 21844097 Free PMC article.
Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.
Kröller-Schön S, Knorr M, Hausding M, Oelze M, Schuff A, Schell R, Sudowe S, Scholz A, Daub S, Karbach S, Kossmann S, Gori T, Wenzel P, Schulz E, Grabbe S, Klein T, Münzel T, Daiber A. Kröller-Schön S, et al. Among authors: hausding m. Cardiovasc Res. 2012 Oct 1;96(1):140-9. doi: 10.1093/cvr/cvs246. Epub 2012 Jul 27. Cardiovasc Res. 2012. PMID: 22843705
Peroxisome proliferator-activated receptor γ, coactivator 1α deletion induces angiotensin II-associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation.
Kröller-Schön S, Jansen T, Schüler A, Oelze M, Wenzel P, Hausding M, Kerahrodi JG, Beisele M, Lackner KJ, Daiber A, Münzel T, Schulz E. Kröller-Schön S, et al. Among authors: hausding m. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1928-35. doi: 10.1161/ATVBAHA.113.301717. Epub 2013 Jun 20. Arterioscler Thromb Vasc Biol. 2013. PMID: 23788763
The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.
Oelze M, Kröller-Schön S, Welschof P, Jansen T, Hausding M, Mikhed Y, Stamm P, Mader M, Zinßius E, Agdauletova S, Gottschlich A, Steven S, Schulz E, Bottari SP, Mayoux E, Münzel T, Daiber A. Oelze M, et al. Among authors: hausding m. PLoS One. 2014 Nov 17;9(11):e112394. doi: 10.1371/journal.pone.0112394. eCollection 2014. PLoS One. 2014. PMID: 25402275 Free PMC article.
CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice.
Steven S, Dib M, Hausding M, Kashani F, Oelze M, Kröller-Schön S, Hanf A, Daub S, Roohani S, Gramlich Y, Lutgens E, Schulz E, Becker C, Lackner KJ, Kleinert H, Knosalla C, Niesler B, Wild PS, Münzel T, Daiber A. Steven S, et al. Among authors: hausding m. Cardiovasc Res. 2018 Feb 1;114(2):312-323. doi: 10.1093/cvr/cvx197. Cardiovasc Res. 2018. PMID: 29036612
Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
Knorr M, Hausding M, Kröller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Münzel T. Knorr M, et al. Among authors: hausding m. Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2223-31. doi: 10.1161/ATVBAHA.111.232058. Epub 2011 Jul 14. Arterioscler Thromb Vasc Biol. 2011. PMID: 21757654
36 results